肝炎検査診断のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Hepatitis Testing Diagnosis Market Insights, Forecast to 2028

• レポートコード：QY2207E09530 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の肝炎検査診断の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に肝炎検査診断の世界市場のxxx％を占める「酵素免疫測定法（ELISA）」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の肝炎検査診断の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの肝炎検査診断市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの肝炎検査診断市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 肝炎検査診断のグローバル主要メーカーには、F. Hoffmann-La Roche、Abbott Laboratories、Siemens Healthineers AG、Bio-Rad Laboratories、Danaher Corporation、QIAGEN、BioMerieux SA、DiaSorin S.P.A.、Ortho Clinical Diagnostics、MedMira Inc、Fujirebio、Grifols、Orasure Technologies、GenMark Diagnostics、Vela Diagnostics、Epitope Diagnostics、Trivitron Healthcare、Meril Life Sciences、geneOmbio Technologies、Molbio Diagnosticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 肝炎検査診断市場は、種類と用途によって区分されます。世界の肝炎検査診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 酵素免疫測定法（ELISA）、迅速診断検査（RDT）、ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、その他 【用途別セグメント】 病院、血液バンク、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 肝炎検査診断製品概要 - 種類別市場（酵素免疫測定法（ELISA）、迅速診断検査（RDT）、ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、その他） - 用途別市場（病院、血液バンク、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の肝炎検査診断販売量予測2017-2028 - 世界の肝炎検査診断売上予測2017-2028 - 肝炎検査診断の地域別販売量 - 肝炎検査診断の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別肝炎検査診断販売量 - 主要メーカー別肝炎検査診断売上 - 主要メーカー別肝炎検査診断価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（酵素免疫測定法（ELISA）、迅速診断検査（RDT）、ポリメラーゼ連鎖反応（PCR）、等温核酸増幅技術（INAAT）、その他） - 肝炎検査診断の種類別販売量 - 肝炎検査診断の種類別売上 - 肝炎検査診断の種類別価格 ・用途別市場規模（病院、血液バンク、その他） - 肝炎検査診断の用途別販売量 - 肝炎検査診断の用途別売上 - 肝炎検査診断の用途別価格 ・北米市場 - 北米の肝炎検査診断市場規模（種類別、用途別） - 主要国別の肝炎検査診断市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの肝炎検査診断市場規模（種類別、用途別） - 主要国別の肝炎検査診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の肝炎検査診断市場規模（種類別、用途別） - 主要国別の肝炎検査診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の肝炎検査診断市場規模（種類別、用途別） - 主要国別の肝炎検査診断市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの肝炎検査診断市場規模（種類別、用途別） - 主要国別の肝炎検査診断市場規模（トルコ、サウジアラビア） ・企業情報 F. Hoffmann-La Roche、Abbott Laboratories、Siemens Healthineers AG、Bio-Rad Laboratories、Danaher Corporation、QIAGEN、BioMerieux SA、DiaSorin S.P.A.、Ortho Clinical Diagnostics、MedMira Inc、Fujirebio、Grifols、Orasure Technologies、GenMark Diagnostics、Vela Diagnostics、Epitope Diagnostics、Trivitron Healthcare、Meril Life Sciences、geneOmbio Technologies、Molbio Diagnostics ・産業チェーン及び販売チャネル分析 - 肝炎検査診断の産業チェーン分析 - 肝炎検査診断の原材料 - 肝炎検査診断の生産プロセス - 肝炎検査診断の販売及びマーケティング - 肝炎検査診断の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 肝炎検査診断の産業動向 - 肝炎検査診断のマーケットドライバー - 肝炎検査診断の課題 - 肝炎検査診断の阻害要因 ・主な調査結果

The purpose of hepatitis tests is to screen for and diagnose hepatitis, evaluate the liver, and to determine the underlying cause of hepatitis
Common hepatitis tests include Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), etc.
Market Analysis and Insights: Global Hepatitis Testing Diagnosis Market
Due to the COVID-19 pandemic, the global Hepatitis Testing Diagnosis market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Enzyme-linked Immunosorbent Assay (ELISA) accounting for % of the Hepatitis Testing Diagnosis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Hepatitis Testing Diagnosis market size is valued at US$ million in 2021, while the US and Europe Hepatitis Testing Diagnosis are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hepatitis Testing Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Hepatitis Testing Diagnosis include F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, Bio-Rad Laboratories, Danaher Corporation, QIAGEN, BioMerieux SA, DiaSorin S.P.A. and Ortho Clinical Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Hepatitis Testing Diagnosis Scope and Segment
Hepatitis Testing Diagnosis market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hepatitis Testing Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
Segment by Application
Hospital
Blood Banks
Other
By Company
F. Hoffmann-La Roche
Abbott Laboratories
Siemens Healthineers AG
Bio-Rad Laboratories
Danaher Corporation
QIAGEN
BioMerieux SA
DiaSorin S.P.A.
Ortho Clinical Diagnostics
MedMira Inc
Fujirebio
Grifols
Orasure Technologies
GenMark Diagnostics
Vela Diagnostics
Epitope Diagnostics
Trivitron Healthcare
Meril Life Sciences
geneOmbio Technologies
Molbio Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Hepatitis Testing Diagnosis Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis Testing Diagnosis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Enzyme-linked Immunosorbent Assay (ELISA)
1.2.3 Rapid Diagnostic Tests (RDT)
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hepatitis Testing Diagnosis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Blood Banks
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis Testing Diagnosis Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis Testing Diagnosis Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis Testing Diagnosis Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis Testing Diagnosis Sales by Region
2.4.1 Global Hepatitis Testing Diagnosis Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis Testing Diagnosis by Region (2023-2028)
2.5 Global Hepatitis Testing Diagnosis Revenue by Region
2.5.1 Global Hepatitis Testing Diagnosis Revenue by Region (2017-2022)
2.5.2 Global Hepatitis Testing Diagnosis Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis Testing Diagnosis Sales by Manufacturers
3.1.1 Global Top Hepatitis Testing Diagnosis Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis Testing Diagnosis Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis Testing Diagnosis in 2021
3.2 Global Hepatitis Testing Diagnosis Revenue by Manufacturers
3.2.1 Global Hepatitis Testing Diagnosis Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis Testing Diagnosis Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis Testing Diagnosis Revenue in 2021
3.3 Global Hepatitis Testing Diagnosis Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis Testing Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis Testing Diagnosis Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis Testing Diagnosis Sales by Type
4.1.1 Global Hepatitis Testing Diagnosis Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis Testing Diagnosis Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis Testing Diagnosis Revenue by Type
4.2.1 Global Hepatitis Testing Diagnosis Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis Testing Diagnosis Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis Testing Diagnosis Price by Type
4.3.1 Global Hepatitis Testing Diagnosis Price by Type (2017-2022)
4.3.2 Global Hepatitis Testing Diagnosis Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis Testing Diagnosis Sales by Application
5.1.1 Global Hepatitis Testing Diagnosis Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis Testing Diagnosis Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis Testing Diagnosis Revenue by Application
5.2.1 Global Hepatitis Testing Diagnosis Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis Testing Diagnosis Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis Testing Diagnosis Price by Application
5.3.1 Global Hepatitis Testing Diagnosis Price by Application (2017-2022)
5.3.2 Global Hepatitis Testing Diagnosis Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis Testing Diagnosis Market Size by Type
6.1.1 North America Hepatitis Testing Diagnosis Sales by Type (2017-2028)
6.1.2 North America Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
6.2 North America Hepatitis Testing Diagnosis Market Size by Application
6.2.1 North America Hepatitis Testing Diagnosis Sales by Application (2017-2028)
6.2.2 North America Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
6.3 North America Hepatitis Testing Diagnosis Market Size by Country
6.3.1 North America Hepatitis Testing Diagnosis Sales by Country (2017-2028)
6.3.2 North America Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis Testing Diagnosis Market Size by Type
7.1.1 Europe Hepatitis Testing Diagnosis Sales by Type (2017-2028)
7.1.2 Europe Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
7.2 Europe Hepatitis Testing Diagnosis Market Size by Application
7.2.1 Europe Hepatitis Testing Diagnosis Sales by Application (2017-2028)
7.2.2 Europe Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
7.3 Europe Hepatitis Testing Diagnosis Market Size by Country
7.3.1 Europe Hepatitis Testing Diagnosis Sales by Country (2017-2028)
7.3.2 Europe Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis Testing Diagnosis Market Size by Type
8.1.1 Asia Pacific Hepatitis Testing Diagnosis Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis Testing Diagnosis Market Size by Application
8.2.1 Asia Pacific Hepatitis Testing Diagnosis Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis Testing Diagnosis Market Size by Region
8.3.1 Asia Pacific Hepatitis Testing Diagnosis Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis Testing Diagnosis Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Hepatitis Testing Diagnosis Market Size by Type
9.1.1 Latin America Hepatitis Testing Diagnosis Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
9.2 Latin America Hepatitis Testing Diagnosis Market Size by Application
9.2.1 Latin America Hepatitis Testing Diagnosis Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
9.3 Latin America Hepatitis Testing Diagnosis Market Size by Country
9.3.1 Latin America Hepatitis Testing Diagnosis Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis Testing Diagnosis Market Size by Type
10.1.1 Middle East and Africa Hepatitis Testing Diagnosis Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis Testing Diagnosis Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis Testing Diagnosis Market Size by Application
10.2.1 Middle East and Africa Hepatitis Testing Diagnosis Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis Testing Diagnosis Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis Testing Diagnosis Market Size by Country
10.3.1 Middle East and Africa Hepatitis Testing Diagnosis Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis Testing Diagnosis Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 F. Hoffmann-La Roche Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Siemens Healthineers AG
11.3.1 Siemens Healthineers AG Corporation Information
11.3.2 Siemens Healthineers AG Overview
11.3.3 Siemens Healthineers AG Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Siemens Healthineers AG Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Siemens Healthineers AG Recent Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Corporation Information
11.4.2 Bio-Rad Laboratories Overview
11.4.3 Bio-Rad Laboratories Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio-Rad Laboratories Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio-Rad Laboratories Recent Developments
11.5 Danaher Corporation
11.5.1 Danaher Corporation Corporation Information
11.5.2 Danaher Corporation Overview
11.5.3 Danaher Corporation Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Danaher Corporation Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Danaher Corporation Recent Developments
11.6 QIAGEN
11.6.1 QIAGEN Corporation Information
11.6.2 QIAGEN Overview
11.6.3 QIAGEN Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 QIAGEN Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 QIAGEN Recent Developments
11.7 BioMerieux SA
11.7.1 BioMerieux SA Corporation Information
11.7.2 BioMerieux SA Overview
11.7.3 BioMerieux SA Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 BioMerieux SA Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BioMerieux SA Recent Developments
11.8 DiaSorin S.P.A.
11.8.1 DiaSorin S.P.A. Corporation Information
11.8.2 DiaSorin S.P.A. Overview
11.8.3 DiaSorin S.P.A. Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 DiaSorin S.P.A. Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 DiaSorin S.P.A. Recent Developments
11.9 Ortho Clinical Diagnostics
11.9.1 Ortho Clinical Diagnostics Corporation Information
11.9.2 Ortho Clinical Diagnostics Overview
11.9.3 Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ortho Clinical Diagnostics Recent Developments
11.10 MedMira Inc
11.10.1 MedMira Inc Corporation Information
11.10.2 MedMira Inc Overview
11.10.3 MedMira Inc Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 MedMira Inc Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 MedMira Inc Recent Developments
11.11 Fujirebio
11.11.1 Fujirebio Corporation Information
11.11.2 Fujirebio Overview
11.11.3 Fujirebio Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Fujirebio Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Fujirebio Recent Developments
11.12 Grifols
11.12.1 Grifols Corporation Information
11.12.2 Grifols Overview
11.12.3 Grifols Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Grifols Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Grifols Recent Developments
11.13 Orasure Technologies
11.13.1 Orasure Technologies Corporation Information
11.13.2 Orasure Technologies Overview
11.13.3 Orasure Technologies Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Orasure Technologies Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Orasure Technologies Recent Developments
11.14 GenMark Diagnostics
11.14.1 GenMark Diagnostics Corporation Information
11.14.2 GenMark Diagnostics Overview
11.14.3 GenMark Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 GenMark Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 GenMark Diagnostics Recent Developments
11.15 Vela Diagnostics
11.15.1 Vela Diagnostics Corporation Information
11.15.2 Vela Diagnostics Overview
11.15.3 Vela Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Vela Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Vela Diagnostics Recent Developments
11.16 Epitope Diagnostics
11.16.1 Epitope Diagnostics Corporation Information
11.16.2 Epitope Diagnostics Overview
11.16.3 Epitope Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Epitope Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Epitope Diagnostics Recent Developments
11.17 Trivitron Healthcare
11.17.1 Trivitron Healthcare Corporation Information
11.17.2 Trivitron Healthcare Overview
11.17.3 Trivitron Healthcare Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Trivitron Healthcare Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Trivitron Healthcare Recent Developments
11.18 Meril Life Sciences
11.18.1 Meril Life Sciences Corporation Information
11.18.2 Meril Life Sciences Overview
11.18.3 Meril Life Sciences Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Meril Life Sciences Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Meril Life Sciences Recent Developments
11.19 geneOmbio Technologies
11.19.1 geneOmbio Technologies Corporation Information
11.19.2 geneOmbio Technologies Overview
11.19.3 geneOmbio Technologies Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 geneOmbio Technologies Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 geneOmbio Technologies Recent Developments
11.20 Molbio Diagnostics
11.20.1 Molbio Diagnostics Corporation Information
11.20.2 Molbio Diagnostics Overview
11.20.3 Molbio Diagnostics Hepatitis Testing Diagnosis Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Molbio Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Molbio Diagnostics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis Testing Diagnosis Industry Chain Analysis
12.2 Hepatitis Testing Diagnosis Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis Testing Diagnosis Production Mode & Process
12.4 Hepatitis Testing Diagnosis Sales and Marketing
12.4.1 Hepatitis Testing Diagnosis Sales Channels
12.4.2 Hepatitis Testing Diagnosis Distributors
12.5 Hepatitis Testing Diagnosis Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis Testing Diagnosis Industry Trends
13.2 Hepatitis Testing Diagnosis Market Drivers
13.3 Hepatitis Testing Diagnosis Market Challenges
13.4 Hepatitis Testing Diagnosis Market Restraints
14 Key Findings in The Global Hepatitis Testing Diagnosis Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Hepatitis Testing Diagnosis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Enzyme-linked Immunosorbent Assay (ELISA)
Table 3. Major Manufacturers of Rapid Diagnostic Tests (RDT)
Table 4. Major Manufacturers of Polymerase Chain Reaction (PCR)
Table 5. Major Manufacturers of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 6. Major Manufacturers of Others
Table 7. Global Hepatitis Testing Diagnosis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Hepatitis Testing Diagnosis Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Hepatitis Testing Diagnosis Sales by Region (2017-2022) & (K Units)
Table 10. Global Hepatitis Testing Diagnosis Sales Market Share by Region (2017-2022)
Table 11. Global Hepatitis Testing Diagnosis Sales by Region (2023-2028) & (K Units)
Table 12. Global Hepatitis Testing Diagnosis Sales Market Share by Region (2023-2028)
Table 13. Global Hepatitis Testing Diagnosis Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Hepatitis Testing Diagnosis Revenue Market Share by Region (2017-2022)
Table 15. Global Hepatitis Testing Diagnosis Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Hepatitis Testing Diagnosis Revenue Market Share by Region (2023-2028)
Table 17. Global Hepatitis Testing Diagnosis Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Hepatitis Testing Diagnosis Sales Share by Manufacturers (2017-2022)
Table 19. Global Hepatitis Testing Diagnosis Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Hepatitis Testing Diagnosis Revenue Share by Manufacturers (2017-2022)
Table 21. Hepatitis Testing Diagnosis Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Hepatitis Testing Diagnosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Hepatitis Testing Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis Testing Diagnosis as of 2021)
Table 24. Hepatitis Testing Diagnosis Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Hepatitis Testing Diagnosis Product Offered
Table 26. Date of Manufacturers Enter into Hepatitis Testing Diagnosis Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hepatitis Testing Diagnosis Sales by Type (2017-2022) & (K Units)
Table 29. Global Hepatitis Testing Diagnosis Sales by Type (2023-2028) & (K Units)
Table 30. Global Hepatitis Testing Diagnosis Sales Share by Type (2017-2022)
Table 31. Global Hepatitis Testing Diagnosis Sales Share by Type (2023-2028)
Table 32. Global Hepatitis Testing Diagnosis Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Hepatitis Testing Diagnosis Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Hepatitis Testing Diagnosis Revenue Share by Type (2017-2022)
Table 35. Global Hepatitis Testing Diagnosis Revenue Share by Type (2023-2028)
Table 36. Hepatitis Testing Diagnosis Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Hepatitis Testing Diagnosis Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Hepatitis Testing Diagnosis Sales by Application (2017-2022) & (K Units)
Table 39. Global Hepatitis Testing Diagnosis Sales by Application (2023-2028) & (K Units)
Table 40. Global Hepatitis Testing Diagnosis Sales Share by Application (2017-2022)
Table 41. Global Hepatitis Testing Diagnosis Sales Share by Application (2023-2028)
Table 42. Global Hepatitis Testing Diagnosis Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Hepatitis Testing Diagnosis Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Hepatitis Testing Diagnosis Revenue Share by Application (2017-2022)
Table 45. Global Hepatitis Testing Diagnosis Revenue Share by Application (2023-2028)
Table 46. Hepatitis Testing Diagnosis Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Hepatitis Testing Diagnosis Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Hepatitis Testing Diagnosis Sales by Type (2017-2022) & (K Units)
Table 49. North America Hepatitis Testing Diagnosis Sales by Type (2023-2028) & (K Units)
Table 50. North America Hepatitis Testing Diagnosis Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Hepatitis Testing Diagnosis Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Hepatitis Testing Diagnosis Sales by Application (2017-2022) & (K Units)
Table 53. North America Hepatitis Testing Diagnosis Sales by Application (2023-2028) & (K Units)
Table 54. North America Hepatitis Testing Diagnosis Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Hepatitis Testing Diagnosis Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Hepatitis Testing Diagnosis Sales by Country (2017-2022) & (K Units)
Table 57. North America Hepatitis Testing Diagnosis Sales by Country (2023-2028) & (K Units)
Table 58. North America Hepatitis Testing Diagnosis Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Hepatitis Testing Diagnosis Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Hepatitis Testing Diagnosis Sales by Type (2017-2022) & (K Units)
Table 61. Europe Hepatitis Testing Diagnosis Sales by Type (2023-2028) & (K Units)
Table 62. Europe Hepatitis Testing Diagnosis Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Hepatitis Testing Diagnosis Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Hepatitis Testing Diagnosis Sales by Application (2017-2022) & (K Units)
Table 65. Europe Hepatitis Testing Diagnosis Sales by Application (2023-2028) & (K Units)
Table 66. Europe Hepatitis Testing Diagnosis Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Hepatitis Testing Diagnosis Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Hepatitis Testing Diagnosis Sales by Country (2017-2022) & (K Units)
Table 69. Europe Hepatitis Testing Diagnosis Sales by Country (2023-2028) & (K Units)
Table 70. Europe Hepatitis Testing Diagnosis Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Hepatitis Testing Diagnosis Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Hepatitis Testing Diagnosis Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Hepatitis Testing Diagnosis Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Hepatitis Testing Diagnosis Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Hepatitis Testing Diagnosis Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Hepatitis Testing Diagnosis Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Hepatitis Testing Diagnosis Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Hepatitis Testing Diagnosis Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Hepatitis Testing Diagnosis Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Hepatitis Testing Diagnosis Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Hepatitis Testing Diagnosis Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Hepatitis Testing Diagnosis Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Hepatitis Testing Diagnosis Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Hepatitis Testing Diagnosis Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Hepatitis Testing Diagnosis Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Hepatitis Testing Diagnosis Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Hepatitis Testing Diagnosis Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Hepatitis Testing Diagnosis Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Hepatitis Testing Diagnosis Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Hepatitis Testing Diagnosis Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Hepatitis Testing Diagnosis Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Hepatitis Testing Diagnosis Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Hepatitis Testing Diagnosis Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Hepatitis Testing Diagnosis Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Hepatitis Testing Diagnosis Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Hepatitis Testing Diagnosis Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Hepatitis Testing Diagnosis Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Hepatitis Testing Diagnosis Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Hepatitis Testing Diagnosis Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Hepatitis Testing Diagnosis Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Hepatitis Testing Diagnosis Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Hepatitis Testing Diagnosis Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Hepatitis Testing Diagnosis Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Hepatitis Testing Diagnosis Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Hepatitis Testing Diagnosis Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Hepatitis Testing Diagnosis Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Hepatitis Testing Diagnosis Revenue by Country (2023-2028) & (US$ Million)
Table 108. F. Hoffmann-La Roche Corporation Information
Table 109. F. Hoffmann-La Roche Description and Major Businesses
Table 110. F. Hoffmann-La Roche Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. F. Hoffmann-La Roche Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. F. Hoffmann-La Roche Recent Developments
Table 113. Abbott Laboratories Corporation Information
Table 114. Abbott Laboratories Description and Major Businesses
Table 115. Abbott Laboratories Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Abbott Laboratories Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Abbott Laboratories Recent Developments
Table 118. Siemens Healthineers AG Corporation Information
Table 119. Siemens Healthineers AG Description and Major Businesses
Table 120. Siemens Healthineers AG Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Siemens Healthineers AG Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Siemens Healthineers AG Recent Developments
Table 123. Bio-Rad Laboratories Corporation Information
Table 124. Bio-Rad Laboratories Description and Major Businesses
Table 125. Bio-Rad Laboratories Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Bio-Rad Laboratories Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Bio-Rad Laboratories Recent Developments
Table 128. Danaher Corporation Corporation Information
Table 129. Danaher Corporation Description and Major Businesses
Table 130. Danaher Corporation Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Danaher Corporation Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Danaher Corporation Recent Developments
Table 133. QIAGEN Corporation Information
Table 134. QIAGEN Description and Major Businesses
Table 135. QIAGEN Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. QIAGEN Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. QIAGEN Recent Developments
Table 138. BioMerieux SA Corporation Information
Table 139. BioMerieux SA Description and Major Businesses
Table 140. BioMerieux SA Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. BioMerieux SA Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. BioMerieux SA Recent Developments
Table 143. DiaSorin S.P.A. Corporation Information
Table 144. DiaSorin S.P.A. Description and Major Businesses
Table 145. DiaSorin S.P.A. Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. DiaSorin S.P.A. Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. DiaSorin S.P.A. Recent Developments
Table 148. Ortho Clinical Diagnostics Corporation Information
Table 149. Ortho Clinical Diagnostics Description and Major Businesses
Table 150. Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Ortho Clinical Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Ortho Clinical Diagnostics Recent Developments
Table 153. MedMira Inc Corporation Information
Table 154. MedMira Inc Description and Major Businesses
Table 155. MedMira Inc Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. MedMira Inc Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. MedMira Inc Recent Developments
Table 158. Fujirebio Corporation Information
Table 159. Fujirebio Description and Major Businesses
Table 160. Fujirebio Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Fujirebio Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Fujirebio Recent Developments
Table 163. Grifols Corporation Information
Table 164. Grifols Description and Major Businesses
Table 165. Grifols Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 166. Grifols Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Grifols Recent Developments
Table 168. Orasure Technologies Corporation Information
Table 169. Orasure Technologies Description and Major Businesses
Table 170. Orasure Technologies Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 171. Orasure Technologies Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Orasure Technologies Recent Developments
Table 173. GenMark Diagnostics Corporation Information
Table 174. GenMark Diagnostics Description and Major Businesses
Table 175. GenMark Diagnostics Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 176. GenMark Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. GenMark Diagnostics Recent Developments
Table 178. Vela Diagnostics Corporation Information
Table 179. Vela Diagnostics Description and Major Businesses
Table 180. Vela Diagnostics Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 181. Vela Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Vela Diagnostics Recent Developments
Table 183. Epitope Diagnostics Corporation Information
Table 184. Epitope Diagnostics Description and Major Businesses
Table 185. Epitope Diagnostics Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 186. Epitope Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Epitope Diagnostics Recent Developments
Table 188. Trivitron Healthcare Corporation Information
Table 189. Trivitron Healthcare Description and Major Businesses
Table 190. Trivitron Healthcare Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 191. Trivitron Healthcare Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Trivitron Healthcare Recent Developments
Table 193. Meril Life Sciences Corporation Information
Table 194. Meril Life Sciences Description and Major Businesses
Table 195. Meril Life Sciences Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 196. Meril Life Sciences Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 197. Meril Life Sciences Recent Developments
Table 198. geneOmbio Technologies Corporation Information
Table 199. geneOmbio Technologies Description and Major Businesses
Table 200. geneOmbio Technologies Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 201. geneOmbio Technologies Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 202. geneOmbio Technologies Recent Developments
Table 203. Molbio Diagnostics Corporation Information
Table 204. Molbio Diagnostics Description and Major Businesses
Table 205. Molbio Diagnostics Hepatitis Testing Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 206. Molbio Diagnostics Hepatitis Testing Diagnosis Product Model Numbers, Pictures, Descriptions and Specifications
Table 207. Molbio Diagnostics Recent Developments
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Hepatitis Testing Diagnosis Distributors List
Table 211. Hepatitis Testing Diagnosis Customers List
Table 212. Hepatitis Testing Diagnosis Market Trends
Table 213. Hepatitis Testing Diagnosis Market Drivers
Table 214. Hepatitis Testing Diagnosis Market Challenges
Table 215. Hepatitis Testing Diagnosis Market Restraints
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis Testing Diagnosis Product Picture
Figure 3. Global Hepatitis Testing Diagnosis Market Share by Type in 2021 & 2028
Figure 3. Enzyme-linked Immunosorbent Assay (ELISA) Product Picture
Figure 4. Rapid Diagnostic Tests (RDT) Product Picture
Figure 5. Polymerase Chain Reaction (PCR) Product Picture
Figure 6. Isothermal Nucleic Acid Amplification Technology (INAAT) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Hepatitis Testing Diagnosis Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Blood Banks
Figure 11. Other
Figure 12. Hepatitis Testing Diagnosis Report Years Considered
Figure 13. Global Hepatitis Testing Diagnosis Sales 2017-2028 (K Units)
Figure 14. Global Hepatitis Testing Diagnosis Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Hepatitis Testing Diagnosis Revenue 2017-2028 (US$ Million)
Figure 16. Global Hepatitis Testing Diagnosis Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Hepatitis Testing Diagnosis Sales Market Share by Region (2017-2022)
Figure 18. Global Hepatitis Testing Diagnosis Sales Market Share by Region (2023-2028)
Figure 19. North America Hepatitis Testing Diagnosis Sales YoY (2017-2028) & (K Units)
Figure 20. North America Hepatitis Testing Diagnosis Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Hepatitis Testing Diagnosis Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Hepatitis Testing Diagnosis Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Hepatitis Testing Diagnosis Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Hepatitis Testing Diagnosis Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Hepatitis Testing Diagnosis Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Hepatitis Testing Diagnosis Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Hepatitis Testing Diagnosis Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Hepatitis Testing Diagnosis Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Hepatitis Testing Diagnosis Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Hepatitis Testing Diagnosis in the World: Market Share by Hepatitis Testing Diagnosis Revenue in 2021
Figure 31. Global Hepatitis Testing Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
Figure 33. Global Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
Figure 34. Global Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
Figure 35. Global Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
Figure 36. North America Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
Figure 37. North America Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
Figure 38. North America Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
Figure 39. North America Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
Figure 40. North America Hepatitis Testing Diagnosis Sales Share by Country (2017-2028)
Figure 41. North America Hepatitis Testing Diagnosis Revenue Share by Country (2017-2028)
Figure 42. United States Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
Figure 45. Europe Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
Figure 46. Europe Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
Figure 47. Europe Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
Figure 48. Europe Hepatitis Testing Diagnosis Sales Share by Country (2017-2028)
Figure 49. Europe Hepatitis Testing Diagnosis Revenue Share by Country (2017-2028)
Figure 50. Germany Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 51. France Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Hepatitis Testing Diagnosis Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Hepatitis Testing Diagnosis Revenue Share by Region (2017-2028)
Figure 61. China Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 64. India Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
Figure 71. Latin America Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
Figure 73. Latin America Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Hepatitis Testing Diagnosis Sales Share by Country (2017-2028)
Figure 75. Latin America Hepatitis Testing Diagnosis Revenue Share by Country (2017-2028)
Figure 76. Mexico Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 79. Colombia Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Hepatitis Testing Diagnosis Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Hepatitis Testing Diagnosis Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Hepatitis Testing Diagnosis Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Hepatitis Testing Diagnosis Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Hepatitis Testing Diagnosis Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Hepatitis Testing Diagnosis Revenue Share by Country (2017-2028)
Figure 86. Turkey Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Hepatitis Testing Diagnosis Revenue (2017-2028) & (US$ Million)
Figure 89. Hepatitis Testing Diagnosis Value Chain
Figure 90. Hepatitis Testing Diagnosis Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

---